Pre Market Gap Trading Indications

Gapping up in reaction to strong earnings/guidance: CPWR +18.0%, HSR +9.7%, ADTN +7.6%, PII +7.2%, EXPO +6.8%, RF +5.9%, CTBK +5.2%, INFY +4.8%, IMOS +4.2%, NG +3.9%, JBHT +2.5%, USB +2.3%, STT +2.1%, JNJ +1.0%...

M&A news: NWA +10.1% and DAL +5.0% (Delta, Northwest agree to merge)...

Solar names showing strength following select co specific news: ASTI +5.1% (Ascent Solar and Icopal SAS sign cooperation agreement), SOL +5.0% (signs six-year wafer supply agreements with Ningbo Solar and Eoplly New Energy), SOLF +4.2%, LDK +4.2%, CSIQ +2.8%, FSLR +2.5% (Signs 20 yr utility scale PPA with Southern California Edison; tgt raised to $315 - Broadpoint), ESLR +2.4%, SPWR +2.3%, JASO +2.2%...

Other news: PPHM +19.1% (says preclinical study shows its anti-ps immunocytokines can generate protective immune responses in a highly aggressive breast cancer model), SUPG +11.6% (announced its DNA methyltransferase inhibitor, improves in vivo efficacy of decitabine; also announces its clinical-stage multi-targeted tyrosine kinase inhibitor and Rad51 suppressor, is bioavailable and safe in humans ), AZN +5.8% (reaches Ranbaxy settlement - Financial Times), UAUA +5.5% and CAL +5.1% (Continental and United ready if others merge, according to sources - Reuters.com), DNDN +2.5% (immune booster fights breast cancer in clinical trial - Bloomberg.com; also Capital Ventures International discloses 8.6% stake in 13G filing), MRK +2.2% (up in sympathy with JNJ)...

Analyst upgrades: MEE +2.8% (upgraded to Overweight at JPMorgan), FCX +1.5% (Hearing FCX upped at HSBC to Overweight), MT +1.3% (upgraded to Buy from Hold at Citigro